Table 3.
Test–retest effects of latent cognitive and behavioral domains from the intention to treat placebo group1
Total complete case population | n | Test‐retest effects, placebo group only | ||||||
---|---|---|---|---|---|---|---|---|
Baseline | Baseline | 16 weeks | ICC | |||||
M | SD | M | SD | M | SD | |||
Latent variable | ||||||||
EF/attention | 0.01 | 0.23 | 50 | −0.02 | 0.25 | −0.04 | 0.24 | 0.83 |
Visuospatial | 0.04 | 0.38 | 50 | −0.02 | 0.37 | −0.08 | 0.41 | 0.78 |
Memory | 0.02 | 0.48 | 50 | −0.03 | 0.45 | −0.07 | 0.39 | 0.66 |
Behavior | 0.03 | 0.51 | 50 | 0.04 | 0.53 | −0.02 | 0.53 | 0.84 |
Abbreviations: EF, Executive functioning; ICC, Intraclass correlation coefficient; M, Mean; SD, Standard deviation.
Multiple imputation applied to all placebo cases with baseline data (20 replications).